Sumary of New WHO report highlights the alarming state of global access to insulin and diabetes care:
- A new report published by WHO in the lead-up to World Diabetes Day highlights the alarming state of global access to insulin and diabetes care, and finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.
- The scientists who discovered insulin 100 years ago refused to profit from their discovery and sold the patent for just one dollar.
- ” Dr Tedros Adhanom Ghebreyesus, WHO Director-General Insulin is the bedrock of diabetes treatment – it turns a deadly disease into a manageable one for nine million people with type 1 diabetes.
- For more than 60 million people living with type 2 diabetes, insulin is essential in reducing the risk of kidney failure, blindness and limb amputation.
- However, one out of every two people needing insulin for type 2 diabetes does not get it.
- Diabetes is on the rise in low- and middle-income countries, and yet their consumption of insulin has not kept up with the growing disease burden.
- The report highlights that while three in four people affected by type 2 diabetes live in countries outside of North America and Europe, they account for less than 40% of the revenue from insulin sales.
- In general, human insulin is as effective as analogues, but analogues are at least 1.5 times more expensive than human insulins, and in some countries three times more expensive;